Two cholesterol derivative-based PEGylated liposomes as drug delivery system, study on pharmacokinetics and drug delivery to retina

Nanotechnology

Volumn 25, Issue 27, 2014, Pages

  Geng, Shengyong ^a   Yang, Bin ^a   Wang, Guowu ^a   Qin, Geng ^a   Wada, Satoshi ^b   Wang, Jin Ye ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b RIKEN   (Japan)

Author keywords

cholesterol derivative; PEGylated liposome; pharmacokinetics; physical stability; rat retina

Indexed keywords

AZOBENZENE; CHOLESTEROL; DRUG DELIVERY; PHARMACOKINETICS; PHOSPHOLIPIDS; RATS;

CIRCULATION HALF-LIFES; DRUG DELIVERY SYSTEM; DRUG RETENTION; LOCAL DRUG DELIVERY; PEGYLATED LIPOSOMES; PHYSICAL STABILITY; POSITIVELY CHARGED; SYSTEMIC CIRCULATION;

LIPOSOMES;

ANTINEOPLASTIC ANTIBIOTIC; CHOLESTEROL; DOXORUBICIN; LIPOSOME; MACROGOL DERIVATIVE;

ANALOGS AND DERIVATIVES; ANIMAL; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG EFFECTS; FEMALE; PROCEDURES; RAT; RETINA; SPRAGUE DAWLEY RAT; SYNTHESIS; ULTRASTRUCTURE;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CHOLESTEROL; DOXORUBICIN; DRUG DELIVERY SYSTEMS; FEMALE; LIPOSOMES; POLYETHYLENE GLYCOLS; RATS; RATS, SPRAGUE-DAWLEY; RETINA;

EID: 84903288696     PISSN: 09574484     EISSN: 13616528     Source Type: Journal    
DOI: 10.1088/0957-4484/25/27/275103     Document Type: Article

References (50)

1. Torchilin V P 2006 Multifunctional nanocarriers Adv. Drug Deliv. Rev. 58 1532-55 (Pubitemid 44822608)
2. Saad M, Garbuzenko O B and Minko T 2008 Co-delivery of siRNA and an anticancer drug for treatment of multidrug-resistant cancer Nanomedicine 3 761-76
3. Park K 2012 Comparative study on liposome targeting to tumor endothelium J. Control. Release 158 181
4. Swenson C E, Perkins W R, Roberts P and Janoff A S 2001 Liposome technology and the development of myocet™ (liposomal doxorubicin citrate) Breast 10 1-7 (Pubitemid 32529854)
5. Safra T, Muggia F, Jeffers S, Tsao-Wei D D, Groshen S, Lyass O, Henderson R, Berry G and Gabizon A 2000 Pegylated liposomal doxorubicin (doxil): reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg m-2 Ann. Oncol. 11 1029-33
6. Kuang Y, Liu J, Liu Z and Zhuo R 2012 Cholesterol-based anionic long-circulating cisplatin liposomes with reduced renal toxicity Biomaterials 33 1596-606
7. Abu Lila A S, Kizuki S, Doi Y, Suzuki T, Ishida T and Kiwada H 2009 Oxaliplatin encapsulated in PEG-coated cationic liposomes induces significant tumor growth suppression via a dual-targeting approach in a murine solid tumor model J. Control. Release 137 8-14
8. Nakamori K, Nakajima T, Odawara M, Koyama I, Nemoto M, Yoshida T, Ohshima H and Inoue K 1993 Stable positively charged liposome during long-term storage Chem. Pharmaceut. Bull. 41 1279-83 (Pubitemid 23279410)
9. Yeagle P L, Albert A D, Boesze-Battaglia K, Young J and Frye J 1990 Cholesterol dynamics in membranes Biophys. J. 57 413-24 (Pubitemid 20090178)
10. Semple S C, Chonn A and Cullis P R 1998 Interactions of liposomes and lipid-based carrier systems with blood proteins: relation to clearance behaviour in vivo Adv. Drug Deliv. Rev. 32 3-17 (Pubitemid 28277172)
11. Huang L and Guo S 2011 Nanoparticles escaping RES and endosome: challenges for siRNA delivery for cancer therapy J. Nanomater. 2011 742895
12. Oku N, Tokudome Y, Namba Y, Saito N, Endo M, Hasegawa Y, Kawai M, Tsukada H and Okada S 1996 Effect of serum protein binding on real-time trafficking of liposomes with different charges analyzed by positron emission tomography Biochim. Biophys. Acta - Biomembranes 1280 149-54 (Pubitemid 26108319)
13. Lian T and Ho R J Y 2001 Trends and developments in liposome drug delivery systems J. Pharmaceut. Sci. 90 667-80 (Pubitemid 32530443)
14. Huang S K, Mayhew E, Gilani S, Lasic D D, Martin F J and Papahadjopoulos D 1992 Pharmacokinetics and therapeutics of sterically stabilized liposomes in mice bearing C-26 colon carcinoma Cancer Res. 52 6774-81 (Pubitemid 23006277)
15. Janoria K G, Hariharan S, Dasari C R and Mitra A K 2007 Recent patents and advances in ophthalmic drug delivery Recent Patents Drug Deliv. Formulation 1 161-70
16. Sampat K M and Garg S J 2010 Complications of intravitreal injections Current Opinion Ophthalmol. 21 178-83
17. Mishra G P, Bagui M, Tamboli V and Mitra A K 2011 Recent applications of liposomes in ophthalmic drug delivery J. Drug Deliv. 2011 863734
18. Peyman G A, Schulman J A, Khoobehi B, Alkan H M, Tawakol M E and Mani H 1989 Toxicity and clearance of a combination of liposome-encapsulated ganciclovir and trifluridine Retina 9 232-6 (Pubitemid 19262188)
19. Yang B, Geng S Y, Liu X M, Wang J T, Chen Y K, Wang Y L and Wang J Y 2012 Positively charged cholesterol derivative combined with liposomes as an efficient drug delivery system, in vitro and in vivo study Soft Matter 8 518-25
20. Liu X M, Yang B, Wang Y L and Wang J Y 2005 Photoisomerisable cholesterol derivatives as photo-trigger of liposomes: effect of lipid polarity, temperature, incorporation ratio, and cholesterol Biochim. Biophys. Acta - Biomembranes 1720 28-34 (Pubitemid 43202132)
21. Mayer L D, Tai L C L, Bally M B, Mitilenes G N, Ginsberg R S and Cullis P R 1990 Characterization of liposomal systems containing doxorubicin entrapped in response to pH gradients Biochim. Biophys. Acta - Biomembranes 1025 143-51 (Pubitemid 20199621)
22. Mashaghi A, Partovi-Azar P, Jadidi T, Nafari N, Maass P, Tabar M R, Bonn M and Bakker H J 2012 Hydration strongly affects the molecular and electronic structure of membrane phospholipids J. Chem. Phys. 136 114709
23. Zhao W, Zhuang S and Qi X R 2011 Comparative study of the in vitro and in vivo characteristics of cationic and neutral liposomes Int. J. Nanomed. 6 3087-98
24. Nie Y, Ji L, Ding H, Xie L, Li L, He B, Wu Y and Gu Z 2012 Cholesterol derivatives based charged liposomes for doxorubicin delivery: preparation, in vitro and in vivo characterization Theranostics 2 1092-103
25. Cevc G and Richardsen H 1999 Lipid vesicles and membrane fusion Adv. Drug Deliv. Rev. 38 207-32 (Pubitemid 29376575)
26. Jones M N and Nicholas A R 1991 The effect of blood serum on the size and stability of phospholipid liposomes Biochim. Biophys. Acta - Biomembranes 1065 145-52
27. Wang Y, Tu S, Li R, Yang X, Liu L and Zhang Q 2010 Cholesterol succinyl chitosan anchored liposomes: preparation, characterization, physical stability, and drug release behavior Nanomed.: Nanotechnol. Biol. Med. 6 471-7
28. Pradhan P, Giri J, Rieken F, Koch C, Mykhaylyk O, Döblinger M, Banerjee R, Bahadur D and Plank C 2010 Targeted temperature sensitive magnetic liposomes for thermo-chemotherapy J. Control. Release 142 108-21
29. Drummond D C, Meyer O, Hong K, Kirpotin D B and Papahadjopoulos D 1999 Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors Pharmacol. Rev. 51 691-743
30. Souhami R L, Patel H M and Ryman B E 1981 The effect of reticuloendothelial blockade on the blood clearance and tissue distribution of liposomes Biochim. Biophys. Acta 674 354-71 (Pubitemid 11037620)
31. Wu J, Lee A, Lu Y and Lee R J 2007 Vascular targeting of doxorubicin using cationic liposomes Int. J. Pharmaceut. 337 329-35 (Pubitemid 46756051)
32. Romberg B, Oussoren C, Snel C J, Hennink W E and Storm G 2007 Effect of liposome characteristics and dose on the pharmacokinetics of liposomes coated with poly(amino acid)s Pharmaceut. Res. 24 2394-401 (Pubitemid 350060711)
33. Jung S H, Seong H, Cho S H, Jeong K S and Shin B C 2009 Polyethylene glycol-complexed cationic liposome for enhanced cellular uptake and anticancer activity Int. J. Pharmaceut. 382 254-61
34. Aoki H, Tottori T, Sakurai F, Fuji K and Miyajima K 1997 Effects of positive charge density on the liposomal surface on disposition kinetics of liposomes in rats Int. J. Pharmaceut. 156 163-74 (Pubitemid 27400004)
35. Working P K, Newman M S, Huang S K, Mayhew E, Vaage J and Lasic D D 1994 Pharmacokinetics, biodistribution and therapeutic efficacy of doxorubicin encapsulated in stealth® liposomes (Doxil®) J. Liposome Res. 4 667-87 (Pubitemid 24130564)
36. Working P K and Dayan A D 1996 Foreword Human Exp. Toxicol. 15 752-85
37. Mamidi R V S, Weng S, Stellar S, Wang C, Yu N, Huang T, Tonelli A, Kelley M, Angiuoli A and Fung M-C 2010 Pharmacokinetics, efficacy and toxicity of different pegylated liposomal doxorubicin formulations in preclinical models: is a conventional bioequivalence approach sufficient to ensure therapeutic equivalence of pegylated liposomal doxorubicin products? Cancer Chemotherapy Pharmacol. 66 1173-84
38. Gabizon A A, Barenholz Y and Bialer M 1993 Prolongation of the circulation time of doxorubicin encapsulated in liposomes containing a polyethylene glycol-derivatized phospholipid - pharmacokinetic studies in rodents and dogs Pharmaceut. Res. 10 703-8 (Pubitemid 23152316)
39. Lajavardi L, Bochot A, Camelo S, Goldenberg B, Naud M C, Behar-Cohen F, Fattal E and de Kozak Y 2007 Downregulation of endotoxin-induced uveitis by intravitreal injection of vasoactive intestinal peptide encapsulated in liposomes Invest. Ophthalmol. Vis. Sci. 48 3230-8 (Pubitemid 351261168)
40. Bochot A, Fattal E, Boutet V, Deverre J R, Jeanny J C, Chacun H and Couvreur P 2002 Intravitreal delivery of oligonucleotides by sterically stabilized liposomes Invest. Ophthalmol. Vis. Sci. 43 253-9 (Pubitemid 34032467)
41. Inokuchi Y, Hironaka K, Fujisawa T, Tozuka Y, Tsuruma K, Shimazawa M, Takeuchi H and Hara H 2010 Physicochemical properties affecting retinal drug/coumarin-6 delivery from nanocarrier systems via eyedrop administration Invest. Ophthalmol. Vis. Sci. 51 3162-70
42. Fattal E and Bochot A 2006 Ocular delivery of nucleic acids: antisense oligonucleotides, aptamers and siRNA Adv. Drug Deliv. Rev. 58 1203-23
43. Camelo S, Lajavardi L, Bochot A, Goldenberg B, Naud M C, Fattal E, Behar-Cohen F and de Kozak Y 2007 Ocular and systemic bio-distribution of rhodamine-conjugated liposomes loaded with VIP injected into the vitreous of lewis rats Mol. Vis. 13 2263-74 (Pubitemid 350268733)
44. Law S L, Huang K J and Chiang C H 2000 Acyclovir-containing liposomes for potential ocular delivery corneal penetration and absorption J. Control. Release 63 135-40 (Pubitemid 30046949)
45. Hathout R M, Mansour S, Mortada N D and Guinedi A S 2007 Liposomes as an ocular delivery system for acetazolamide: in vitro and in vivo studies AAPS PharmSciTech 8 1
46. Bochot A and Fattal E 2012 Liposomes for intravitreal drug delivery: a state of the art J. Control. Release 161 628-34
47. Fiscella R, Peyman G A and Fishman P H 1987 Duration of therapeutic levels of intravitreally injected liposome-encapsulated clindamycin in the rabbit Can. J. Ophthalmol. 22 307-9 (Pubitemid 17163898)
48. Gupta S K, Velpandian T, Dhingra N and Jaiswal J 2000 Intravitreal pharmacokinetics of plain and liposome-entrapped fluconazole in rabbit eyes J. Ocular Pharmacol. Therapeut. 16 511-8
49. Zhang R, He R, Qian J A, Guo J, Xue K and Yuan Y F 2010 Treatment of experimental autoimmune uveoretinitis with intravitreal injection of tacrolimus (FK506) encapsulated in liposomes Invest. Ophthalmol. Vis. Sci. 51 3575-82
50. Chidlow G, Wood J M and Casson R 2007 Pharmacological neuroprotection for glaucoma Drugs 67 725-59 (Pubitemid 46535645)